Agilent Technologies, Inc. (NYSE:A) Stake Decreased by Loring Wolcott & Coolidge Fiduciary Advisors LLP MA

Loring Wolcott & Coolidge Fiduciary Advisors LLP MA lessened its stake in shares of Agilent Technologies, Inc. (NYSE:AGet Rating) by 2.0% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 4,030 shares of the medical research company’s stock after selling 82 shares during the quarter. Loring Wolcott & Coolidge Fiduciary Advisors LLP MA’s holdings in Agilent Technologies were worth $643,000 at the end of the most recent reporting period.

A number of other institutional investors have also bought and sold shares of the business. Chiron Investment Management LLC acquired a new position in Agilent Technologies in the 3rd quarter worth about $14,223,000. Twinbeech Capital LP bought a new stake in shares of Agilent Technologies in the 3rd quarter worth approximately $11,847,000. M&T Bank Corp raised its holdings in shares of Agilent Technologies by 6.4% in the 4th quarter. M&T Bank Corp now owns 51,649 shares of the medical research company’s stock worth $8,246,000 after buying an additional 3,108 shares in the last quarter. Strs Ohio raised its holdings in shares of Agilent Technologies by 14.7% in the 4th quarter. Strs Ohio now owns 28,306 shares of the medical research company’s stock worth $4,519,000 after buying an additional 3,617 shares in the last quarter. Finally, Astrantus Ltd acquired a new position in shares of Agilent Technologies in the 4th quarter worth approximately $303,000.

Shares of NYSE:A traded up $3.07 during trading on Thursday, reaching $123.45. 63,255 shares of the stock were exchanged, compared to its average volume of 2,102,605. Agilent Technologies, Inc. has a 12 month low of $112.64 and a 12 month high of $179.57. The firm has a market cap of $37.08 billion, a PE ratio of 30.55, a PEG ratio of 2.80 and a beta of 1.06. The stock has a 50-day moving average price of $126.88 and a 200-day moving average price of $139.14. The company has a current ratio of 2.19, a quick ratio of 1.64 and a debt-to-equity ratio of 0.53.

Agilent Technologies (NYSE:AGet Rating) last issued its quarterly earnings results on Tuesday, May 24th. The medical research company reported $1.13 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.12 by $0.01. Agilent Technologies had a return on equity of 27.04% and a net margin of 18.70%. The business had revenue of $1.61 billion during the quarter, compared to analysts’ expectations of $1.62 billion. During the same period in the previous year, the company posted $0.97 earnings per share. The firm’s revenue for the quarter was up 5.4% compared to the same quarter last year. On average, sell-side analysts expect that Agilent Technologies, Inc. will post 4.86 earnings per share for the current fiscal year.

The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, July 27th. Investors of record on Tuesday, July 5th will be issued a $0.21 dividend. The ex-dividend date of this dividend is Friday, July 1st. This represents a $0.84 dividend on an annualized basis and a yield of 0.68%. Agilent Technologies’s payout ratio is 21.32%.

In other news, SVP Michael Tang sold 1,210 shares of the stock in a transaction dated Friday, March 18th. The shares were sold at an average price of $136.21, for a total transaction of $164,814.10. The transaction was disclosed in a legal filing with the SEC, which is accessible through the SEC website.

A number of research firms recently weighed in on A. Truist Financial cut Agilent Technologies from a “buy” rating to a “hold” rating in a report on Tuesday, April 19th. The Goldman Sachs Group reissued a “buy” rating and issued a $170.00 target price on shares of Agilent Technologies in a research note on Thursday. StockNews.com raised Agilent Technologies from a “buy” rating to a “strong-buy” rating in a research note on Thursday, May 19th. Cowen lowered their target price on Agilent Technologies from $187.00 to $178.00 and set an “outperform” rating for the company in a research note on Wednesday, February 23rd. Finally, Wells Fargo & Company lowered their target price on Agilent Technologies from $160.00 to $130.00 and set an “equal weight” rating for the company in a research note on Monday, April 25th. Three research analysts have rated the stock with a hold rating, twelve have assigned a buy rating and one has assigned a strong buy rating to the company. Based on data from MarketBeat.com, the stock currently has an average rating of “Buy” and an average price target of $163.62.

Agilent Technologies Company Profile (Get Rating)

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; vacuum pumps, and measurement technologies.

Featured Articles

Institutional Ownership by Quarter for Agilent Technologies (NYSE:A)

Receive News & Ratings for Agilent Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Agilent Technologies and related companies with MarketBeat.com's FREE daily email newsletter.